| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Seres Therapeutics, Inc. | Director | Stock Option (right to buy) | 35,000 | 22 Jun 2023 | Direct | ||
| Axcella Health Inc. | Director | Stock Option (Right to Buy) | 20,000 | 20 May 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MCRB | Seres Therapeutics, Inc. | 22 Jun 2023 | 1 | $0 | 4 | Director | 23 Jun 2023, 17:24 |
| MCRB | Seres Therapeutics, Inc. | 22 Jun 2022 | 1 | $0 | 4 | Director | 24 Jun 2022, 16:31 |
| MCRB | Seres Therapeutics, Inc. | 16 Jun 2021 | 1 | $0 | 4 | Director | 21 Jun 2021, 16:30 |
| AXLA | Axcella Health Inc. | 20 May 2021 | 1 | $0 | 4 | Director | 24 May 2021, 17:16 |